| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |